메뉴 건너뛰기




Volumn 360, Issue 9332, 2002, Pages 528-534

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: A randomised clinical trial

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; RIFAPENTINE;

EID: 0037125569     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09742-8     Document Type: Article
Times cited : (390)

References (33)
  • 1
    • 0032821532 scopus 로고    scopus 로고
    • Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications
    • Fox W., Ellard G.A., Mitchison D.A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 3:1999;S231-S279.
    • (1999) Int J Tuberc Lung Dis , vol.3 , pp. S231-S279
    • Fox, W.1    Ellard, G.A.2    Mitchison, D.A.3
  • 2
    • 0025236718 scopus 로고
    • USPHS tuberculosis short-course chemotherapy trial 21: Effectiveness, toxicity, and acceptability
    • Combs D.L., O'Brien R.J., Geiter L.J. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med. 112:1990;397-406.
    • (1990) Ann Intern Med , vol.112 , pp. 397-406
    • Combs, D.L.1    O'Brien, R.J.2    Geiter, L.J.3
  • 3
    • 0028274105 scopus 로고
    • The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis
    • Weis S.E., Slocum P.C., Blais F.X., et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 330:1994;1179-1184.
    • (1994) N Engl J Med , vol.330 , pp. 1179-1184
    • Weis, S.E.1    Slocum, P.C.2    Blais, F.X.3
  • 4
    • 0025214721 scopus 로고
    • A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: A twice-weekly, directly observed, and cost-effective regimen
    • Cohn D.L., Catlin B.J., Peterson K.L., Judson F.N., Sbarbaro J.A. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med. 112:1990;407-415.
    • (1990) Ann Intern Med , vol.112 , pp. 407-415
    • Cohn, D.L.1    Catlin, B.J.2    Peterson, K.L.3    Judson, F.N.4    Sbarbaro, J.A.5
  • 5
    • 0017550207 scopus 로고
    • Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore: The results up to 30 months
    • Singapore Tuberculosis Service/British Medical Research Council. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore: The results up to 30 months. Am Rev Respir Dis 1977; 116: 807-20.
    • (1977) Am Rev Respir Dis , vol.116 , pp. 807-820
  • 6
    • 0023216341 scopus 로고
    • In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis
    • Dickinson J.M., Mitchison D.A. In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis. Tubercle. 68:1987;113-118.
    • (1987) Tubercle , vol.68 , pp. 113-118
    • Dickinson, J.M.1    Mitchison, D.A.2
  • 7
    • 0027744137 scopus 로고
    • Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice
    • Ji B., Truffot-Pernot C., LaCroix C., et al. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis. 148:1993;1541-1546.
    • (1993) Am Rev Respir Dis , vol.148 , pp. 1541-1546
    • Ji, B.1    Truffot-Pernot, C.2    LaCroix, C.3
  • 8
    • 0032978862 scopus 로고    scopus 로고
    • Single and multiple dose pharmacokinetics of rifapentine in man: Part II
    • Keung A.C., Eller M.G., McKenzie K.A., Weir S.J. Single and multiple dose pharmacokinetics of rifapentine in man: Part II. Int J Tuberc Lung Dis. 3:1999;437-444.
    • (1999) Int J Tuberc Lung Dis , vol.3 , pp. 437-444
    • Keung, A.C.1    Eller, M.G.2    McKenzie, K.A.3    Weir, S.J.4
  • 9
    • 0015169660 scopus 로고
    • Kinetic studies on rifampicin: Serum concentration analysis in subjects treated with different oral doses over a period of two weeks
    • Acocella G., Pagani V., Marchetti M., Baroni G.C., Nicolis F.B. Kinetic studies on rifampicin: serum concentration analysis in subjects treated with different oral doses over a period of two weeks. Chemotherapy. 16:1971;356-370.
    • (1971) Chemotherapy , vol.16 , pp. 356-370
    • Acocella, G.1    Pagani, V.2    Marchetti, M.3    Baroni, G.C.4    Nicolis, F.B.5
  • 10
    • 0028226440 scopus 로고
    • Treatment of tuberculosis and tuberculosis infection in adults and children
    • Bass J.B.J., Farer L.S., Hopewell P.C., et al. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 149:1994;1359-1374.
    • (1994) Am J Respir Crit Care Med , vol.149 , pp. 1359-1374
    • Bass, J.B.J.1    Farer, L.S.2    Hopewell, P.C.3
  • 11
    • 0033614603 scopus 로고    scopus 로고
    • Relapse with rifamycin mono-resistant tuberculosis in HIV-infected patients treated with supervised once-weekly rifapentine and isoniazid
    • Vernon A., Burman W., Benator D., Khan A., Bozeman L. Relapse with rifamycin mono-resistant tuberculosis in HIV-infected patients treated with supervised once-weekly rifapentine and isoniazid. Lancet. 353:1999;1843-1847.
    • (1999) Lancet , vol.353 , pp. 1843-1847
    • Vernon, A.1    Burman, W.2    Benator, D.3    Khan, A.4    Bozeman, L.5
  • 13
    • 0028125708 scopus 로고
    • Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis
    • Cave M.D., Eisenach K.D., Templeton G., et al. Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol. 32:1994;262-266.
    • (1994) J Clin Microbiol , vol.32 , pp. 262-266
    • Cave, M.D.1    Eisenach, K.D.2    Templeton, G.3
  • 14
    • 0029912504 scopus 로고    scopus 로고
    • Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis
    • Chaves F., Yang Z., el Hajj H., et al. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol. 34:1996;1118-1123.
    • (1996) J Clin Microbiol , vol.34 , pp. 1118-1123
    • Chaves, F.1    Yang, Z.2    El Hajj, H.3
  • 15
    • 0031037905 scopus 로고    scopus 로고
    • The incidence of false-positive cultures of Mycobacterium tuberculosis
    • Burman W.J., Stone B.L., Reves R.R., et al. The incidence of false-positive cultures of Mycobacterium tuberculosis. Am J Respir Crit Care Med. 155:1997;321-326.
    • (1997) Am J Respir Crit Care Med , vol.155 , pp. 321-326
    • Burman, W.J.1    Stone, B.L.2    Reves, R.R.3
  • 16
    • 0020668953 scopus 로고
    • 1983 metropolitan height and weight tables
    • 1983 metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64: 3-9.
    • (1983) Stat Bull Metrop Life Found , vol.64 , pp. 3-9
  • 17
    • 0018687930 scopus 로고
    • A multiple testing procedure for clinical trials
    • O'Brien P.C., Fleming T.C. A multiple testing procedure for clinical trials. Biometrics. 35:1979;549-556.
    • (1979) Biometrics , vol.35 , pp. 549-556
    • O'Brien, P.C.1    Fleming, T.C.2
  • 18
    • 0018243820 scopus 로고
    • Factors affecting relapse following short-course chemotherapy
    • Aber V.R., Nunn A.J. Factors affecting relapse following short-course chemotherapy. Bull Int Union Against Tuberculosis. 53:1978;260-264.
    • (1978) Bull Int Union Against Tuberculosis , vol.53 , pp. 260-264
    • Aber, V.R.1    Nunn, A.J.2
  • 19
    • 0019155947 scopus 로고
    • Short-course (6 month) cooperative tuberculosis study in Poland: Results 18 months after completion of treatment
    • Zierski M., Bek E., Long M.W., Snider D.E. Jr. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis. 122:1980;879-889.
    • (1980) Am Rev Respir Dis , vol.122 , pp. 879-889
    • Zierski, M.1    Bek, E.2    Long, M.W.3    Snider, D.E.4
  • 20
    • 0027446941 scopus 로고
    • Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months
    • Mitchison D.A. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis. 147:1993;1062-1063.
    • (1993) Am Rev Respir Dis , vol.147 , pp. 1062-1063
    • Mitchison, D.A.1
  • 22
    • 0031807468 scopus 로고    scopus 로고
    • Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis: Initial report
    • Tam C.M., Chan S.L., Lam C.W., et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis: initial report. Am J Respir Crit Care Med. 157:1998;1726-1733.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 1726-1733
    • Tam, C.M.1    Chan, S.L.2    Lam, C.W.3
  • 25
    • 0000387429 scopus 로고    scopus 로고
    • Low isoniazid (INH) levels are associated with TB treatment failure/relapse with once-weekly rifapentine and INH
    • abstr
    • Weiner M., Khan A., Benator D., Peloquin C., Burman W. Low isoniazid (INH) levels are associated with TB treatment failure/relapse with once-weekly rifapentine and INH. Am J Respir Crit Care Med. 163:2001;A498. (abstr).
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. A498
    • Weiner, M.1    Khan, A.2    Benator, D.3    Peloquin, C.4    Burman, W.5
  • 26
    • 0031856542 scopus 로고    scopus 로고
    • Development of rifapentine: The way ahead
    • Mitchison D.A. Development of rifapentine: the way ahead. Int J Tuberc Lung Dis. 2:1998;612-615.
    • (1998) Int J Tuberc Lung Dis , vol.2 , pp. 612-615
    • Mitchison, D.A.1
  • 27
    • 0025361652 scopus 로고
    • Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis
    • Heifets L.B., Lindhom-Levy P., Flory M.A. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. Am Rev Respir Dis. 141:1990;626-630.
    • (1990) Am Rev Respir Dis , vol.141 , pp. 626-630
    • Heifets, L.B.1    Lindhom-Levy, P.2    Flory, M.A.3
  • 28
    • 0032929038 scopus 로고    scopus 로고
    • Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids
    • Peloquin C.A., Namdar R., Singleton M.D., Nix D.E. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids. Chest. 115:1999;12-18.
    • (1999) Chest , vol.115 , pp. 12-18
    • Peloquin, C.A.1    Namdar, R.2    Singleton, M.D.3    Nix, D.E.4
  • 29
  • 30
    • 0016277961 scopus 로고
    • Binding of rifampicin by human plasma proteins
    • Boman G., Ringberger V.A. Binding of rifampicin by human plasma proteins. Eur J Clin Pharmacol. 7:1974;369-373.
    • (1974) Eur J Clin Pharmacol , vol.7 , pp. 369-373
    • Boman, G.1    Ringberger, V.A.2
  • 31
    • 0036606533 scopus 로고    scopus 로고
    • Tolerability of once-weekly rifapentine 900 mg plus INH vs once-weekly rifapentine 600 mg plus INH during continuation phase treatment of pan-susceptible tuberculosis in HIV-negative adults
    • the Tuberculosis Trials Consortium, Bock N.N., Conwell D.S., Pachucki C.T., Sterling T.R., Wang Y.C. Tolerability of once-weekly rifapentine 900 mg plus INH vs once-weekly rifapentine 600 mg plus INH during continuation phase treatment of pan-susceptible tuberculosis in HIV-negative adults. Am J Respir Crit Care Med. 165:2002;1526-1530.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 1526-1530
    • Bock, N.N.1    Conwell, D.S.2    Pachucki, C.T.3    Sterling, T.R.4    Wang, Y.C.5
  • 32
    • 0005116073 scopus 로고    scopus 로고
    • A prevention effectiveness study of rifapentine in the continuation phase of therapy for active pulmonary tuberculosis
    • abstr
    • Taylor Z., Qualls N., Vernon A., Villarino E., O'Brien R. A prevention effectiveness study of rifapentine in the continuation phase of therapy for active pulmonary tuberculosis. Am J Respir Crit Care Med. 161:2000;A524. (abstr).
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. A524
    • Taylor, Z.1    Qualls, N.2    Vernon, A.3    Villarino, E.4    O'Brien, R.5
  • 33
    • 0026098628 scopus 로고
    • A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong
    • Hong Kong Chest Service, Tuberculosis Research Centre Madras, and British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis 1991; 143: 262-67.
    • (1991) Am Rev Respir Dis , vol.143 , pp. 262-267


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.